Similar articles for PMID: 32060215

Year	Number of Results
1993	2
1995	1
1997	1
1999	1
2000	1
2001	2
2002	2
2003	4
2004	4
2006	4
2007	5
2008	4
2009	8
2010	4
2011	6
2012	4
2013	7
2014	13
2015	10
2016	12
2017	10
2018	8
2019	2
2020	1
2021	0

1

Imaging the Distribution of Gastrin-Releasing Peptide Receptors in Cancer.

Baratto L, Duan H, Mäcke H, Iagaru A. Baratto L, et al. J Nucl Med. 2020 Jun;61(6):792-798. doi: 10.2967/jnumed.119.234971. Epub 2020 Feb 14. J Nucl Med. 2020. PMID: 32060215

2

Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT.

Maina T, Bergsma H, Kulkarni HR, Mueller D, Charalambidis D, Krenning EP, Nock BA, de Jong M, Baum RP. Maina T, et al. Eur J Nucl Med Mol Imaging. 2016 May;43(5):964-973. doi: 10.1007/s00259-015-3232-1. Epub 2015 Dec 2. Eur J Nucl Med Mol Imaging. 2016. PMID: 26631238

3

PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog.

Dijkgraaf I, Franssen GM, McBride WJ, D'Souza CA, Laverman P, Smith CJ, Goldenberg DM, Oyen WJ, Boerman OC. Dijkgraaf I, et al. J Nucl Med. 2012 Jun;53(6):947-52. doi: 10.2967/jnumed.111.100891. Epub 2012 May 8. J Nucl Med. 2012. PMID: 22570329 Free article.

4

Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).

Biddlecombe GB, Rogers BE, de Visser M, Parry JJ, de Jong M, Erion JL, Lewis JS. Biddlecombe GB, et al. Bioconjug Chem. 2007 May-Jun;18(3):724-30. doi: 10.1021/bc060281l. Epub 2007 Mar 23. Bioconjug Chem. 2007. PMID: 17378600

5

Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors.

Baratto L, Jadvar H, Iagaru A. Baratto L, et al. Mol Imaging Biol. 2018 Aug;20(4):501-509. doi: 10.1007/s11307-017-1151-1. Mol Imaging Biol. 2018. PMID: 29256046 Free PMC article. Review.

6

Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.

Nock BA, Kaloudi A, Lymperis E, Giarika A, Kulkarni HR, Klette I, Singh A, Krenning EP, de Jong M, Maina T, Baum RP. Nock BA, et al. J Nucl Med. 2017 Jan;58(1):75-80. doi: 10.2967/jnumed.116.178889. Epub 2016 Aug 4. J Nucl Med. 2017. PMID: 27493272 Free article.

7

Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.

Hoffman TJ, Gali H, Smith CJ, Sieckman GL, Hayes DL, Owen NK, Volkert WA. Hoffman TJ, et al. J Nucl Med. 2003 May;44(5):823-31. J Nucl Med. 2003. PMID: 12732685 Free article.

8

18F-labeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors.

Honer M, Mu L, Stellfeld T, Graham K, Martic M, Fischer CR, Lehmann L, Schubiger PA, Ametamey SM, Dinkelborg L, Srinivasan A, Borkowski S. Honer M, et al. J Nucl Med. 2011 Feb;52(2):270-8. doi: 10.2967/jnumed.110.081620. Epub 2011 Jan 13. J Nucl Med. 2011. PMID: 21233180 Free article.

9

From Bench to Bed: New Gastrin-Releasing Peptide Receptor-Directed Radioligands and Their Use in Prostate Cancer.

Maina T, Nock BA. Maina T, et al. PET Clin. 2017 Apr;12(2):205-217. doi: 10.1016/j.cpet.2016.12.002. Epub 2017 Jan 31. PET Clin. 2017. PMID: 28267454 Review.

10

In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies.

Chatalic KL, Konijnenberg M, Nonnekens J, de Blois E, Hoeben S, de Ridder C, Brunel L, Fehrentz JA, Martinez J, van Gent DC, Nock BA, Maina T, van Weerden WM, de Jong M. Chatalic KL, et al. Theranostics. 2016 Jan 1;6(1):104-17. doi: 10.7150/thno.13580. eCollection 2016. Theranostics. 2016. PMID: 26722377 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed